| Identification | Back Directory | [Name]
Bilirubin Conjugate (sodium salt) | [CAS]
68683-34-1 | [Synonyms]
Ditaurobilirubin disodium salt
Bilirubin Conjugate (sodium salt)
Sodium dithiocarbamate bilirubin / conjugated bilirubin
disodium 2,2'-[(1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-2,17-divinyl-21H-biline-8,12-diyl)bis[(1-oxopropane-3,1-diyl)imino]]bis[ethane-1-sulphonate]
2,2'-[(2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-diyl)bis[(1-oxo-3,1-propanediyl)imino]]bis(ethanesulfonic acid sodium) salt
2,2'-[[(2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline)-8,12-diyl]bis[(1-oxo-3,1-propanediyl)imino]]bis(ethanesulfonic acid sodium) salt
2,2'-[[(2,17-Diethenyl-1,10,19,22,23,24-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline)-8,12-diyl]bis[(1-oxo-3,1-propanediyl)imino]]bis[ethanesulfonic acid sodium] salt
disodium:2-[3-[5-[(E)-(4-ethenyl-3-methyl-5-oxopyrrol-2-ylidene)methyl]-2-[[5-[(E)-(3-ethenyl-4-methyl-5-oxopyrrol-2-ylidene)methyl]-4-methyl-3-[3-oxo-3-(2-sulfonatoethylamino)propyl]-1H-pyrrol-2-yl]methyl]-4-methyl-1H-pyrrol-3-yl]propanoylamino]ethanesulfonate | [EINECS(EC#)]
272-072-3 | [Molecular Formula]
C37H44N6Na2O10S2 | [MDL Number]
MFCD00044931 | [MOL File]
68683-34-1.mol | [Molecular Weight]
842.889 |
| Chemical Properties | Back Directory | [storage temp. ]
Store at -20°C | [solubility ]
DMF: 0.25 mg/ml; DMSO: 10 mg/ml; Water: 5 mg/ml | [form ]
A crystalline solid | [color ]
Orange to red | [EPA Substance Registry System]
Ethanesulfonic acid, 2,2'-[(2,17-diethenyl-1,10,11,19,22,23-hexahydro-3,7,13,18-tetramethyl-1,19-dioxo-21H-biline-8,12-diyl)bis[(1-oxo-3,1-propanediyl)imino]]bis-, disodium salt (68683-34-1) |
| Hazard Information | Back Directory | [Uses]
Bilirubin Conjugate disodium is a ditaurate derivative of Bilirubin. Bilirubin, a major end product of heme breakdown, is an important constituent of bile[1]. | [References]
[1] Eva Sticova, et al. New insights in bilirubin metabolism and their clinical implications. World J Gastroenterol. 2013 Oct 14;19(38):6398-407. DOI:10.3748/wjg.v19.i38.6398 |
|
|